Colossal Biosciences Is Worth $10 Billion and That Is Not a Conservation Story
Colossal Biosciences hit a $10 billion valuation engineering woolly mice in a Dallas lab. The CRISPR toolkit they're building is genuinely valuable. The conservation framing around it is not. Here is why that distinction matters.
By Vera Santos · 3 min read